Principales conclusions et analyse des parts de marché de l'immunothérapie par virus oncolytique d'ici 2025-2031
Oncolytic Virus Immunotherapy Market Report Analysis
Oncolytic Virus Immunotherapy Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Amgen, Inc.
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- TILT Biotherapeutics
- Oncorus, Inc.
- Oncolys BioPharma, Inc.
- Sorrento Therapeutics, Inc.
- Oncolytics Biotech, Inc.
- SillaJen, Inc.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type de virus
- virus de l'herpès simplex
- virus de la vaccine
- adénovirus
- réovirus
- autres
By Voie d'administration
- intratumorale
- intraveineuse
By Application
- mélanome
- cancer du poumon non à petites cellules
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For